Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

Recs

0
Player Avatar BYUofU (48.47) Submitted: 9/14/2013 11:24:46 PM : Outperform Start Price: $1.27 ENZN Score: -29.43

Pipeline, and possible takeover..

Featured Broker Partners


Advertisement